L1CAM and carcinoma: In general, the methodology of these studies involved screening of expression of patient samples and tumor cell lines across a wide array of mostly carcinomas, flanked by overexpression of L1CAM-FL or siRNA-mediated knockdown (KD) in vitro and in vivo.